NYT > Health: F.D.A. Wants More Tests on a Novo Nordisk Insulin, Tresiba

F.D.A. Wants More Tests on a Novo Nordisk Insulin, Tresiba

The request by the F.D.A. for more data on the heart risks of a diabetes drug will delay an important product for Novo Nordisk of Denmark.

Source: http://www.nytimes.com/2013/02/11/business/fda-wants-more-tests-on-a-novo-nordisk-insulin-tresiba.html?partner=rss&emc=rss